| 中文名称 | Lamivudine 拉米夫定 |
|---|---|
| 中文别名 | 拉米夫定;(2R-顺式)-4-氨基-1-(2-羟甲基-1,3-氧硫杂环戊-5-基)-1H-嘧啶-2-酮;拉米呋啶;拉夫米定;拉米呋定;拉米夫啶;(2R-顺式)-4-氨基-1-[2-(羟基甲基)-1,3-嘿噻烷-5-基]-2(1H)-嘧啶酮;2,2,6,6-四甲基-1-(1-苯基乙氧基);Lamivudine 拉米夫定;氨基封端聚二甲基硅氧烷;拉咪夫定;拉米夫定 EP标准品;拉米夫定 USP标准品;拉米夫定 标准品;拉米夫定-13C-D2;拉米夫定Lamivudine;拉米夫定系统适用性1 EP标准品;拉米夫定系统适用性2 EP标准品;拉米呋啶 标准品;拉米呋啶中间体;马来酸依那普利;托吡酯;拉美呋定;拉美呋定杂质A;拉米夫定溶液混合物A |
| 英文别名 | 4-Amino-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one;(2r-cis)-4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1h)-pyrimidinone;3TC;3'-THIA-2',3'-DIDEOXYCYTIDINE;4-AMINO-1-((2R,5S)-2-HYDROXYMETHYL-[1,3]OXATHIOLAN-5-YL)-1H-PYRIMIDIN-2-ONE;(-)-BCH-189;(-)-BETA-L-2',3'-DIDEOXY-3'-THIACYTIDINE;(-)-B-L-2',3'-DIDEOXY-3'-THIACYTIDINE;(-)-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cystosine;(-)-2¢;(-)NGPB-21;(2R-cis)-4-amino-1-;,3¢;2(1H)-Pyrimidinone,4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-,(2R-cis)-;3'-thia-2',3'-dideoxcytidine;-deoxy-3¢;Epivir;GR109714X;-thia-2¢;LAMIVUDINE;Epivir-HBV;2(1H)-Pyrimidinone, 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-;Lamivudine ( 3TC,Epivir-HBV,Epivir®,Heptovir®, Zeffix®);(-)-1-[(2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine;2',3'-Dideoxy-3'-thiacytidine;3&L-SddC;cent;Hepitec;Heptivir;Heptovir;LaMivudine Resolution Mixture A;Zeffix;Zefix;2′,3′-Dideoxy-3′-thiacytidine;2'-Deoxy-3'-thiacytidine;[ "" ];Heptodin;CIS-LAMIVUDINE;(-)-2'-Deoxy-3'-thiacytidine;Lamivudine [USAN:BAN:INN];beta-L-3'-Thia-2',3'-dideoxycytidine;beta-L-2',3'-Dideoxy-3'-thiacytidine;GR 109714X;4-amino-1-[(2R,5S)-2-(hydroxyme;BCH-189;2(1H)-Pyrimidinone, 4-amino-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-;Lamivudine teva;LAMIVUDINE [EP IMPURITY];Lamivudine- Bio-X;4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-Oxathiolan-5-yl]-(1H)-pyrimidin-2-one;BCH 189;LAMIVUDINE COMPONENT OF TRIZIVIR;J-700183;LAMIVUDINE COMPONENT OF TEMIXYS;3TC and NV-01;L0217;Lamivudine (EPIVIR);EN300-123034;JTEGQNOMFQHVDC-NKWVEPMBSA-N;LAMIVUDINE [USP-RS];Lamivudine [USAN:USP:INN:BAN];(+/-) (Cis)-1-[2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine;4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one;Q422631;2(1H)-Pyrimidinone, 4-amino-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-, (2R-cis)-;SR-01000759420;(+/-)-3TC;(+/-)-(cis)-4-Amino-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one;136891-12-8;LAMIVUDINE [USP MONOGRAPH];MLS001424097;Lamivudine for system suitability 1, European Pharmacopoeia (EP) Reference Standard;lamivudine & TNF-alpha & IFN-gamma;Lamivudine 100 microg/mL in Acetonitrile:Water;4-AMINO-1-((2R,5S)-2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL)PYRIMIDIN-2(1H)-ONE [WHO-IP];SMR000466319;BCH 189, (-)-;LAMIVUDINE COMPONENT OF DUTREBIS;Epivir (TN);EPZICOM COMPONENT LAMIVUDINE;P17147;GG-714;NSC620753;.beta.-L-(-)-2',3'-dideoxy-3'-thiacytidine & Sho-Saiko-To;NC00234;LAMIVUDINE/ZIDOVUDINE TEVA COMPONENT LAMIVUDINE;MFCD00869739;Lamivir;Lamivudine, 1.0 mg/mL in methanol, certified reference material;Lamivudine, European Pharmacopoeia (EP) Reference Standard;MLS000759424;4-Amino-1-(cis-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one;LAMIVUDINE [INN];HMS3713C16;NCGC00159341-20;(+/-)-SddC;AKOS015854841;COMBIVIR COMPONENT LAMIVUDINE;GTPL12673;CCRIS 9274;(-)-BCH189;4... |
| CAS号 | 134678-17-4 |
| 分子式 | C8H11N3O3S |
| 分子量 | 229.26 |
| 密度 | 1.7±0.1 g/cm3 |
| 沸点 | 475.4°C at 760 mmHg |
| 蒸汽压 | 0.0±2.7 mmHg at 25°C |
Copyright ©2024 北京睿宸生物科技有限公司 版权所有 备案号：京ICP备2023008432号-1
